Erythromycin 52536-0183-03
- Manufacturer
- Wilshire Pharmaceuticals
- Dosage Form
- Tablet, Delayed Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 22, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA062298
Need to source Erythromycin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erythromycin | 333 mg/1 |
Drug Class
Macrolide [EPC]Macrolide Antimicrobial [EPC]Decreased Sebaceous Gland Activity [PE]
Selected Package
52536-0183-03Selected30 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-183-03)
Other packages for this product(1)
100 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-183-10)